Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Epileptic Syndrome”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Ended earlyNCT01668654
What this trial is testing

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Who this might be right for
Epilepsy
GlaxoSmithKline 4
Not applicableStudy completedNCT04169581
What this trial is testing

A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging

Who this might be right for
Epilepsy, Temporal Lobe
Second Affiliated Hospital, School of Medicine, Zhejiang University 201
Large-scale testing (Phase 3)Active Not RecruitingNCT05818553
What this trial is testing

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Who this might be right for
SCN2A EncephalopathySCN8A Encephalopathy
Praxis Precision Medicines 77
Large-scale testing (Phase 3)Looking for participantsNCT06872125
What this trial is testing

Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 170
Large-scale testing (Phase 3)Study completedNCT00236743
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90
Large-scale testing (Phase 3)Study completedNCT01405053
What this trial is testing

Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs

Who this might be right for
Lennox-Gastaut Syndrome
Eisai Inc. 37
Not applicableUnknownNCT02766595
What this trial is testing

Does Body Positioning Affect the Yield of Hyperventilation in Routine Pediatric Electroencephalography - EEG Studies?

Who this might be right for
Epilepsy, Absence
Meir Medical Center 50
Not applicableAvailableNCT03778424
What this trial is testing

An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303

Who this might be right for
Lennox Gastaut Syndrome
Eisai Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04015141
What this trial is testing

Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Who this might be right for
Pediatric Epileptic SyndromePartial-onset Seizures
Eisai Inc. 100
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Not applicableNot Yet RecruitingNCT07396883
What this trial is testing

Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing

Who this might be right for
Developmental and Epileptic EncephalopathyEpilepsy in Children
University Hospital, Strasbourg, France 20
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Not applicableWithdrawnNCT05462054
What this trial is testing

Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy

Who this might be right for
STXBP1 Encephalopathy with Epilepsy
Capsida Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Large-scale testing (Phase 3)Looking for participantsNCT07019922
What this trial is testing

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

Who this might be right for
Epileptic EncephalopathySCN2A Encephalopathy
Praxis Precision Medicines 40
Testing effectiveness (Phase 2)Study completedNCT04625101
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Who this might be right for
Epileptic EncephalopathyContinuous Spike and Wave During Sleep
Neurocrine Biosciences 24
Testing effectiveness (Phase 2)Study completedNCT00544050
What this trial is testing

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Who this might be right for
Epilepsy
UCB Pharma 13
Testing effectiveness (Phase 2)Study completedNCT04442295
What this trial is testing

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 62
Not applicableLooking for participantsNCT06924086
What this trial is testing

The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial

Who this might be right for
Lennox Gastaut Syndrome (LGS)
University College, London 22
Testing effectiveness (Phase 2)Ended earlyNCT00442104
What this trial is testing

Open-label Extension to Protocol 1042-0500

Who this might be right for
Infantile Spasms
Marinus Pharmaceuticals 54
Load More Results